calendar
7,763 catalysts · 5,159 phase readout · 2,286 8k filing · 315 pdufa · 256 earnings · 2 approval · 1 adcom
next 91 dayslessmore
MonWedFri
7,763 catalysts · 5,159 phase readout · 2,286 8k filing · 315 pdufa · 256 earnings · 2 approval · 1 adcom
Sponsor: Wake Forest University Health Sciences. Phase: NA. Conditions: Food Insecurities, Cardiometabolic Comorbidities, HIV, PreDiabetes, Type 2 Diabetes Mellitus (T2DM)
Sponsor: Stanford University. Phase: . Conditions: Atrial Fibrillation, Arrhythmias, Cardiac
Sponsor: Catholic University of the Sacred Heart. Phase: NA. Conditions: Oral Lichen Planus, Biopsy
Sponsor: Suven Life Sciences Limited. Phase: PHASE2. Conditions: Major Depressive Disorder
Sponsor: Sinovac Biotech Co., Ltd. Phase: PHASE3. Conditions: Epidemic Meningitis, Meningococcal Vaccines
Sponsor: Uganda Cancer Institute. Phase: PHASE2. Conditions: Cervical Cancer, Cervix Cancer, Cervical Adenocarcinoma, Cervical Small Cell Carcinoma, Cervical Adenosquamous Carcinoma
Sponsor: Karolinska Institutet. Phase: NA. Conditions: Neoplasm, Colorectal, Neoplasm, Breast, Neoplasm, Ovarian
Sponsor: Case Western Reserve University. Phase: NA. Conditions: Pregnancy Related, Food Insecurity, Premature Birth, Pregnancy Complications
Sponsor: Hospices Civils de Lyon. Phase: . Conditions: Patients With Anterior Open Bite Malocclusion and Who Benefited of an Orthognathic Surgery, Infantile Swallowing and Tongue Malposition Necessitating Tongue Rehabilitation
Sponsor: ECOG-ACRIN Cancer Research Group. Phase: PHASE2. Conditions: Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm, Steroid-Refractory Pneumonitis
Sponsor: Nippon Medical School. Phase: PHASE4. Conditions: Lacunar Stroke, Stroke, Ischemic Stroke
Sponsor: Boehringer Ingelheim. Phase: PHASE1. Conditions: Advanced Relapsed or Refractory Germ Cell Tumours, Advanced Relapsed or Refractory Endometrial Cancer, Advanced Relapsed or Refractory Ovarian Cancer
Sponsor: Chulalongkorn University. Phase: EARLY_PHASE1. Conditions: Relapsed/Refractory Multiple Myeloma (MM)
Sponsor: Organon and Co. Phase: PHASE3. Conditions: Atopic Dermatitis
Sponsor: Zhihong LU. Phase: NA. Conditions: Anesthesia, Postoperative Delirium, Electroencephalogram
Sponsor: Poseida Therapeutics, Inc.. Phase: PHASE1. Conditions: Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, High-grade B-cell Lymphoma, Primary Mediastinal Large B-cell Lymphoma (PMBCL), Transformed Follicular Lymphoma (tFL), Follicular Lymphoma Grade 3B, DLBCL, DLBCL - Diffuse Large B Cell Lymphoma, DLBCL Arising From Follicular Lymphoma, DLBCL, Diffused Large B Cell Lymphoma, DLBCL NOS
Sponsor: Dana-Farber Cancer Institute. Phase: PHASE1. Conditions: Lung Cancer Squamous Cell, Solid Tumors, Head & Neck Cancer, Pancreatic Cancer
Sponsor: Natera, Inc.. Phase: NA. Conditions: Heart Transplant Failure and Rejection
Sponsor: University of Oregon. Phase: EARLY_PHASE1. Conditions: Postexercise Hypotension
Sponsor: Asan Medical Center. Phase: PHASE2. Conditions: Stage III Breast Cancer
Sponsor: City of Hope Medical Center. Phase: NA. Conditions: Thyroid Gland Carcinoma
Sponsor: Inari Medical. Phase: . Conditions: Deep Vein Thrombosis
Sponsor: Dana-Farber Cancer Institute. Phase: PHASE1. Conditions: Multiple Myeloma
Sponsor: Rijnstate Hospital. Phase: . Conditions: Post-Anoxic Coma, Postanoxic Enchephalopathie
Sponsor: HuidaGene Therapeutics Co., Ltd.. Phase: EARLY_PHASE1. Conditions: Duchenne Muscular Dystrophin (DMD)
Sponsor: Hatice Semrin Timlioglu İper. Phase: . Conditions: Cortical Visual Impairment, Visual Function
Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital. Phase: PHASE4. Conditions: Mitral Regurgitation
Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain. Phase: NA. Conditions: Brain Tumor
Sponsor: Virginia Commonwealth University. Phase: NA. Conditions: Stroke
Sponsor: University of Florida. Phase: NA. Conditions: Essential Tremor
Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla. Phase: PHASE1. Conditions: Sclerosis, Multiple, Autoimmune Diseases of the Nervous System, Nervous System Diseases, Autoimmune Diseases
Sponsor: University of Medicine and Pharmacy at Ho Chi Minh City. Phase: NA. Conditions: Shoulder Tendinopathy, Shoulder Tendinitis
Sponsor: Memorial Sloan Kettering Cancer Center. Phase: . Conditions: Skin Cancer
Sponsor: University of Crete. Phase: NA. Conditions: Medication Overuse, Deprescriptions, Polypharmacy, Frailty Syndrome
Sponsor: Seoul National University Hospital. Phase: . Conditions: Adult Double Unit Cord Blood Transplant
Sponsor: Icahn School of Medicine at Mount Sinai. Phase: NA. Conditions: Cerebral Palsy
Sponsor: Universitair Ziekenhuis Brussel. Phase: NA. Conditions: Breast Neoplasms, Survivors, Chronic Pain
Sponsor: Universidad de Granada. Phase: . Conditions: COVID-19
Sponsor: University Hospital, Strasbourg, France. Phase: . Conditions: Febrile Crisis
Sponsor: Johns Hopkins University. Phase: . Conditions: Ventilator Associated Pneumonia, Tracheobronchitis
Sponsor: University of Virginia. Phase: EARLY_PHASE1. Conditions: Prolonged Grief Disorder
Sponsor: Memorial Sloan Kettering Cancer Center. Phase: PHASE2. Conditions: Intrahepatic Cholangiocarcinoma
Sponsor: International Dental Contiuing Education. Phase: NA. Conditions: Internal Sinus Lifting
Sponsor: University of Valencia. Phase: NA. Conditions: Aging, Adults With Overweight and Obesity, Supplementation, Exercise
Sponsor: Hofseth Biocare ASA. Phase: NA. Conditions: Supplementation in Healthy Adults to Assess Impact on Omega 3 Index and Cardiometabolic Health
Sponsor: Monte Rosa Therapeutics, Inc. Phase: PHASE1. Conditions: NSCLC, SCLC, High Grade Neuroendocrine Cancer, DLBCL, L-MYC and N-MYC Amplified Solid Tumors, NSCLC With High or Low L-MYC or N-MYC Expression, HR-positive, HER2-negative Breast Cancer, Prostate Cancer
Sponsor: Cairo University. Phase: NA. Conditions: Sublingual, Caffeine, Recovery Time, Postoperative Agitation, Elderly Patients, General Anesthesia
Sponsor: Min Su. Phase: EARLY_PHASE1. Conditions: Esketamine, ECT, Depression, Adolescent
Sponsor: Regend Therapeutics. Phase: EARLY_PHASE1. Conditions: Chronic Obstructive Pulmonary Disease (COPD)
Sponsor: Duke University. Phase: NA. Conditions: Hypertension, HIV